---
layout: page
title: Opportunities in the lab
description: Publications
---
2024

* [Interleukin-21 engineering enhances NK cell activity against glioblastoma via CEBPD.](https://www.cell.com/cancer-cell/abstract/S1535-6108(24)00272-1) <br/>S, Mayra, M Daher, **J Dou**, S Li, R Basar, H Rafei, M Dede et al. **Cancer cell** 42, no. 8 (2024): 1450-1466.
